Yasuhiro Tsutani Selected Research

Culture Media

6/2020

Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuhiro Tsutani Research Topics

Disease

47	Neoplasms (Cancer) 01/2024 - 01/2006
39	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 07/2011
34	Lung Neoplasms (Lung Cancer) 04/2024 - 01/2012
22	Adenocarcinoma of Lung 04/2024 - 12/2012
12	Adenocarcinoma 11/2022 - 05/2006
9	Lymphatic Metastasis 12/2023 - 12/2012
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2022 - 07/2011
5	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2008
5	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023 - 09/2019
5	Stomach Neoplasms (Stomach Cancer) 07/2013 - 01/2008
4	Margins of Excision 01/2021 - 01/2018
4	Breast Neoplasms (Breast Cancer) 06/2020 - 06/2005
3	Malignant Mesothelioma 02/2021 - 01/2019
2	Carcinoma (Carcinomatosis) 04/2022 - 01/2007
2	Lung Injury 01/2022 - 12/2021
2	Disease Progression 12/2018 - 07/2017
2	Esophageal Neoplasms (Esophageal Cancer) 09/2008 - 01/2007
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2007 - 03/2006
1	Respiratory Insufficiency (Respiratory Failure) 01/2024
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2024
1	Leukemia 01/2023
1	Acute Lung Injury 01/2022
1	Emphysema 07/2021
1	Fibrosis (Cirrhosis) 06/2021
1	Fistula 03/2021
1	Bronchial Fistula 02/2021
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2021
1	Idiopathic Pulmonary Fibrosis 09/2020
1	Anorexia 01/2020
1	Esophageal Squamous Cell Carcinoma 01/2020
1	Mesothelioma 03/2019
1	Hypoxia (Hypoxemia) 12/2015
1	Fanconi Anemia (Fanconi's Anemia) 07/2013
1	Colonic Neoplasms (Colon Cancer) 07/2013

Drug/Important Bio-Agent (IBA)

11	Deoxyglucose (2 Deoxy D glucose)IBA 01/2023 - 07/2011
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2006
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2013
3	LigandsIBA 09/2023 - 01/2020
3	Carcinoembryonic AntigenIBA 03/2019 - 11/2012
3	Fluorouracil (Carac)FDA LinkGeneric 07/2013 - 12/2008
3	Orotate PhosphoribosyltransferaseIBA 12/2008 - 01/2007
2	xylometazoline (stas)IBA 04/2024 - 01/2021
2	Tyrosine Kinase InhibitorsIBA 09/2023 - 01/2023
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 11/2022
2	S100 Calcium-Binding Protein A4IBA 01/2023 - 06/2021
2	Bevacizumab (Avastin)FDA Link 04/2022 - 12/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2022 - 12/2008
2	Immune Checkpoint InhibitorsIBA 01/2021 - 09/2019
2	NivolumabIBA 01/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 06/2020 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 12/2018
2	Indicators and Reagents (Reagents)IBA 01/2016 - 07/2011
2	DNA (Deoxyribonucleic Acid)IBA 07/2013 - 02/2012
2	Docetaxel (Taxotere)FDA Link 07/2009 - 12/2008
2	SOXB1 Transcription FactorsIBA 05/2006 - 03/2006
2	Gastric MucinsIBA 05/2006 - 03/2006
1	mobocertinibIBA 09/2023
1	osimertinibIBA 01/2023
1	Carboplatin (JM8)FDA LinkGeneric 04/2022
1	Receptor for Advanced Glycation End ProductsIBA 01/2022
1	HMGB1 Protein (HMG1)IBA 12/2021
1	Carbon MonoxideIBA 07/2021
1	GlypicansIBA 02/2021
1	Therapeutic UsesIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 06/2020
1	Transfer RNA (tRNA)IBA 06/2020
1	Culture MediaIBA 06/2020
1	Protein Isoforms (Isoforms)IBA 06/2020
1	B7-H1 AntigenIBA 01/2020
1	GhrelinIBA 01/2020
1	GlobulinsIBA 01/2020
1	liu-jun-zi-tangIBA 01/2020
1	Circulating MicroRNAIBA 01/2020
1	AlbuminsIBA 01/2020
1	Carrier Proteins (Binding Protein)IBA 10/2019
1	Mucin-4IBA 03/2019
1	MucinsIBA 03/2019
1	Claudin-4IBA 03/2019
1	AsbestosIBA 01/2019
1	Pemetrexed (MTA)FDA Link 12/2018
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 12/2015
1	Keratin-19 (Keratin 19)IBA 06/2015
1	Hormones (Hormone)IBA 10/2013
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 07/2013

Therapy/Procedure

41	Segmental Mastectomy (Lumpectomy) 01/2024 - 01/2012
13	Lymph Node Excision (Lymph Node Dissection) 12/2023 - 12/2012
11	Operative Surgical Procedures 01/2023 - 01/2014
9	Adjuvant Chemotherapy 11/2022 - 06/2005
7	Drug Therapy (Chemotherapy) 04/2022 - 01/2008
7	Therapeutics 02/2021 - 01/2007
4	Pneumonectomy (Lung Volume Reduction) 02/2021 - 07/2017
2	Immunotherapy 09/2023 - 01/2021
2	Radiotherapy 03/2021 - 12/2017
2	Aftercare (After-Treatment) 01/2019 - 09/2012
1	Operative Time 01/2024
1	Combined Modality Therapy 03/2021
1	Pleurodesis 03/2021
1	Induction Chemotherapy 12/2018
1	Maintenance Chemotherapy 12/2018
1	Neoadjuvant Therapy 07/2017